Celsius Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Celsius Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects (NCT05901883) | Celsius Therapeutics, Inc. | 2023-06-20 |
Track Celsius Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.